消化器・腸内治療薬の市場規模、シェア、動向分析レポート：タイプ別、年齢層別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

消化器・腸内治療薬市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の消化器・腸内治療薬市場規模は2025～2030年にかけてCAGR 4.25%で拡大し、2030年には275億4,000万米ドルに達すると推定されています。

消化器治療薬は、人々が購入する最も一般的な市販薬です。さらに、医師は、胃酸過多やその他の消化器治療薬などの軽度の健康問題の後にのみ、これらの医薬品の使用を推奨しています。しかし、いくつかの国では、これらの医薬品は、その国の規則や規制に従って、配合箋なしで患者に直接販売されています。

市場は、zientac、omezなどの市販品への高い需要が主要要因となっています。人々の間で胃腸障害の症例が増加しています。さらに、炎症性腸疾患、便秘、過敏性腸症候群、胃食道逆流症などの症例が増加していることも、予測期間中の市場成長を後押しする要因となっています。

市場成長の原動力となっているのは、ファーストフード店や外食産業の開発と拡大です。ホテル、レストラン、ジャンクフード店の世界の拡大により、油っぽく、スパイシーで、不衛生な食品の消費が極端に増加しています。さらに、可処分所得の増加や多忙なライフスタイルが外食の動向を促進しています。このことは、胃酸過多、胃のむかつき、炎症などの消化器系や腸系の問題を著しく引き起こし、消化器系や腸系の治療の消費を増大させています。

COVID-19のパンデミックの際には、世界的に消化器・腸内治療薬の売上が減少しました。COVID-19の蔓延を抑えるための封鎖措置と衛生状態の改善により、季節性疾病の蔓延が凍結されたため、市販薬の売上が減少しました。様々な製薬会社が四半期決算報告書を発表しているが、消化器・腸内治療薬の減少が市場の売上高に影響を及ぼしています。

消化器治療薬は、健康問題の高まりによる需要の増加により、2021年には50%を超える最大の売上シェアを占めました。高齢化人口の増加も、このセグメントの成長を促進する重要な要因です。さらに、ライフスタイルや食生活の変化も消化器治療薬の需要を高めています。したがって、これらの理由により、このセグメントは推定期間中に成長を示すと推定されます。

オフラインセグメントは2021年に70％以上の高いシェアで市場を独占しました。他のどのチャネルよりもオフライン店舗が提供する持続可能性が高いため、消化器・腸内治療薬の需要は顧客の間で高まっています。したがって、このセグメントは評価期間中に成長を示すと予測されます。

北米は市場を独占しており、この地域における胃腸疾患の増加により、2021年には約45％の収益シェアを占めました。また、同地域における高齢者と肥満人口の増加が市場成長の原動力となっています。その他の市場開拓要因としては、研究開発活動の活発化と主要市場参入企業の存在が挙げられます。

消化器・腸内治療市場レポートハイライト

• アジア太平洋の消化器・腸内治療市場は、消化器疾患の有病率増加による消化器・腸内治療需要の高まりにより、世界的に最も速い成長が見込まれています。
• 2024年、消化器治療薬が51.98%超の最大売上シェアを占めたが、これは健康問題の高まりによるこれらの医薬品需要の増加によるものです。
• 市場セグメンテーションは、売上増加により2024年に4.11％の最高シェアで市場を独占しました。
• 胃腸疾患治療薬セグメントは、胃腸疾患治療薬の研究開発の増加により、予測期間中に大きな市場成長を記録すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 消化器・腸管治療市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 消化器・腸管治療市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 消化・腸内治療薬市場：タイプ別、推定・動向分析

• 世界の消化器・腸内治療薬市場：タイプセグメントダッシュボード
• 世界の消化器・腸内治療薬市場：タイプ変動分析
• タイプ別、収益
• 消化器治療薬
• 胃腸疾患治療薬
• 天然と合成薬

第5章 消化・腸内治療薬市場：年齢層別、推定・動向分析

• 世界の消化器・腸内治療薬市場：年齢層セグメントダッシュボード
• 世界の消化器・腸内治療薬市場：年齢層変動分析
• 年齢層別、収益
• 成人と高齢者
• 小児

第6章 消化器・腸管治療市場：流通チャネル別、推定・動向分析

• 世界の消化器・腸内治療薬市場：流通チャネルセグメントダッシュボード
• 世界の消化器・腸内治療薬市場：流通チャネル変動分析
• 流通チャネル別、収益
• オフライン
• オンライン

第7章 消化器・腸内治療薬市場：製品、用途、最終用途、地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析、2024年
  • Bayer AG
  • Johnson & Johnson Services Inc.
  • GSK plc.
  • Procter &Gamble
  • Sanofi
  • Boehringer Ingelheim GmbH
  • Reckitt Benckiser Group PLC
  • Abbott
  • Takeda Pharmaceutical Company Limited
  • Menarini Group

List of Tables

• Table 1 List of abbreviation
• Table 2 North America digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
• Table 3 North America digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 4 North America digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 5 North America digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 6 U.S. digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 7 U.S. digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 8 U.S. digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 9 Canada digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 10 Canada digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 11 Canada digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 12 Mexico digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 13 Mexico digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 14 Mexico digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 15 Europe digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
• Table 16 Europe digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 17 Europe digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 18 Europe digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 19 Germany digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 20 Germany digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 21 Germany digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 22 UK digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 23 UK digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 24 UK digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 25 France digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 26 France digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 27 France digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 28 Italy digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 29 Italy digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 30 Italy digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 31 Spain digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 32 Spain digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 33 Spain digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 34 Denmark digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 35 Denmark digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 36 Denmark digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 37 Sweden digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 38 Sweden digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 39 Norway digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 40 Norway digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 41 Norway digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 45 Aisa Pacific digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 46 China digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 47 China digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 48 China digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 49 Japan digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 50 Japan digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 51 Japan digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 52 India digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 53 India digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 54 India digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55 South Korea digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 56 South Korea digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 57 South Korea digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 58 Australia digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 59 Australia digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 60 Australia digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 61 Thailand digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 62 Thailand digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 63 Thailand digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 64 Latin America digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
• Table 65 Latin America digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 66 Latin America digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 67 Latin America digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 68 Brazil digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 69 Brazil digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 70 Brazil digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 71 Argentina digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 72 Argentina digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 73 Argentina digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 74 MEA digestive & intestinal remedies market, by region, 2018 - 2030 (USD Million)
• Table 75 MEA digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 76 MEA digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 77 MEA digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 78 South Africa digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 79 South Africa digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 80 South Africa digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 81 Saudi Arabia digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 84 UAE digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 85 UAE digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 86 UAE digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)
• Table 87 Kuwait digestive & intestinal remedies market, by type, 2018 - 2030 (USD Million)
• Table 88 Kuwait digestive & intestinal remedies market, by age group, 2018 - 2030 (USD Million)
• Table 89 Kuwait digestive & intestinal remedies market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Digestive & intestinal remedies market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Digestive & intestinal remedies market segment snapshot
• Fig. 10 Digestive & intestinal remedies market competitive snapshot
• Fig. 11 Digestive & intestinal remedies market driver impact
• Fig. 12 Digestive & intestinal remedies market restraint impact
• Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 14 Porter's five forces analysis
• Fig. 15 Value chain analysis
• Fig. 16 Digestive & intestinal remedies market: Type outlook and key takeaways
• Fig. 17 Digestive & intestinal remedies market: Type movement analysis
• Fig. 18 Digestive medicines market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Remedies against gastrointestinal complaints market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Natural and synthetic agents market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Digestive & Intestinal Remedies market: Age Group outlook and key takeaways
• Fig. 22 Digestive & Intestinal Remedies market: Age Group movement analysis
• Fig. 23 Adult & geriatric market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Digestive & intestinal remedies market: Distribution channel outlook and key takeaways
• Fig. 26 Digestive & intestinal remedies market: Distribution channel movement analysis
• Fig. 27 Offline market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Online market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Global digestive & intestinal remedies market: Regional movement analysis
• Fig. 30 Global digestive & intestinal remedies market: Regional outlook and key takeaways
• Fig. 31 Global digestive & intestinal remedies market share and leading players
• Fig. 32 North America, by country
• Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 U.S. key country dynamics
• Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Canada key country dynamics
• Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Mexico key country dynamics
• Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 UK key country dynamics
• Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Germany key country dynamics
• Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 France key country dynamics
• Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Italy key country dynamics
• Fig. 48 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Spain key country dynamics
• Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Denmark key country dynamics
• Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Sweden key country dynamics
• Fig. 54 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Norway key country dynamics
• Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 China key country dynamics
• Fig. 59 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Japan key country dynamics
• Fig. 61 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 India key country dynamics
• Fig. 63 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Thailand key country dynamics
• Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 South Korea key country dynamics
• Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Australia key country dynamics
• Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Brazil key country dynamics
• Fig. 72 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Argentina key country dynamics
• Fig. 74 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 South Africa key country dynamics
• Fig. 77 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Saudi Arabia key country dynamics
• Fig. 79 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 UAE key country dynamics
• Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Kuwait key country dynamics
• Fig. 83 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Market share Analysis of key market players, 2024

Digestive & Intestinal Remedies Market Growth & Trends:

The global digestive & intestinal remedies market size is estimated to reach USD 27.54 billion by 2030, expanding at a CAGR of 4.25% from 2025 to 2030, according to a new report by Grand View Research, Inc. Digestive medicines are the most common over the counter medicines purchased by people. Moreover, physicians recommend the use of these medicines only after minor health issues such as acidity and other digestive problems. But in several countries, these medicines are sold directly to the patients without prescription as per their rules and regulations.

The market is majorly driven by high demand for over-the-counter products such as zientac, omez, and others. There is an increase in gastrointestinal disorders cases among people. Moreover, increasing cases of inflammatory bowel disease, constipation, irritable bowel syndrome, and gastroesophageal reflux illness are other factors that in turn are boosting market growth over the forecast period.

The market growth is driven by the developments and expansion of fast-food joints and the food service industry. Due to the expansion of hotels, restaurants, and junk food places across the world, consumption of oily, spicy, and unhygienic food has increased extremely. Moreover, increasing disposable income and a hectic lifestyle are facilitating the trend of eating out. This significantly leads to digestive and intestinal problems such as acidity, upset stomach, inflammations, etc., and increases consumption of digestive and intestinal remedies.

During the COVID-19 pandemic, the sales of digestive and intestinal remedies were reduced globally. Lockdown measures to control the spread of COVID-19 and better hygiene have frozen the spread of seasonal illnesses, which has reduced the sales of over-the-counter medicines. Various pharmaceutical companies have displayed quarterly earnings reports which showed that a decrease in digestive and intestinal remedies has affected their bottom line sales in the market.

The digestive medicines accounted for the largest revenue share of over 50% in 2021 owing to the increasing demand for these drugs due to rising health issues. The rising aging population is also another key factor driving the segment growth. Moreover, altering lifestyles and diets has also increased the demand for digestive remedies products. Hence, owing to these reasons the segment is estimated to show growth over the estimated period.

The offline segment dominated the market with the highest share of over 70% in 2021. The demand for digestives & intestinal remedies is rising among customers due to more sustainability offered by these offline stores than any other channel. Hence the segment is projected to show growth during the assessment period.

North America dominated the market and accounted for around 45% revenue share in 2021 due to the growing number of gastrointestinal diseases in this region. Also, the growing geriatric and obese population in this region is driving the market growth. Increasing research and development activities along with the presence of key market players are other factors boosting market growth over the forecast period.

Digestive & Intestinal Remedies Market Report Highlights:

• Asia Pacific digestive & intestinal remedies market is expected to experience the fastest growth globally owing to rising demand for digestives & intestinal remedies due to the increasing prevalence of GI illness disease
• The digestive medicines accounted for the largest revenue share of over 51.98% in 2024 owing to the increasing demand for these drugs due to rising health issues
• The offline segment dominated the market with the highest share of 4.11% in 2024 owing to its increasing sales
• The remedies against gastrointestinal complaints segment is expected to register significant market growth during the forecast period owing to growing research and development in remedies against gastrointestinal complaints.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Age group
  • 1.2.3. Distribution channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product and age group outlook
  • 2.2.2. Distribution channel outlook
• 2.3. Competitive Insights

Chapter 3. Digestive & Intestinal Remedies Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of digestive disorders
    • 3.2.1.2. Rising awareness about disease
    • 3.2.1.3. Technological advancement
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations pertaining to drug approval
    • 3.2.2.2. Market saturation and high competition
• 3.3. Digestive & Intestinal Remedies Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Digestive & Intestinal Remedies Market: Type Estimates & Trend Analysis

• 4.1. Global Digestive & Intestinal Remedies Market: Type Segment Dashboard
• 4.2. Global Digestive & Intestinal Remedies Market: Type Movement Analysis
• 4.3. Global Digestive & Intestinal Remedies Market Estimates and Forecasts, By Type, Revenue (USD Million)
• 4.4. Digestive Medicines
  • 4.4.1. Digestive medicines market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Remedies Against Gastrointestinal Complaints
  • 4.5.1. Remedies against gastrointestinal complaints market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Natural and Synthetic Agents
  • 4.6.1. Natural and synthetic agents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Digestive & Intestinal Remedies Market: Age Group Estimates & Trend Analysis

• 5.1. Global Digestive & Intestinal Remedies Market: Age Group Segment Dashboard
• 5.2. Global Digestive & Intestinal Remedies Market: Age Group Movement Analysis
• 5.3. Global Digestive & Intestinal Remedies Market Estimates and Forecasts, By Age Group, Revenue (USD Million)
• 5.4. Adult & Geriatric
  • 5.4.1. Adult & geriatric market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Pediatric
  • 5.5.1. Pediatric market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Digestive & Intestinal Remedies Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Global Digestive & Intestinal Remedies Market: Distribution Channel Segment Dashboard
• 6.2. Global Digestive & Intestinal Remedies Market: Distribution Channel Movement Analysis
• 6.3. Global Digestive & Intestinal Remedies Market Estimates and Forecasts, by Distribution Channel, Revenue (USD Million)
• 6.4. Offline
  • 6.4.1. Offline market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Online
  • 6.5.1. Online market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Digestive & Intestinal Remedies Market: Regional Estimates & Trend Analysis By Product, Application, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. Key company market share analysis, 2024
  • 8.3.2. Bayer AG
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Johnson & Johnson Services Inc.
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. GSK plc.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Procter & Gamble
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Sanofi
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Boehringer Ingelheim GmbH
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Reckitt Benckiser Group PLC
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Abbott
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Takeda Pharmaceutical Company Limited
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Menarini Group
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives